Iovance Biotherapeutics, Inc. (IOVA)
9.195
+0.60
(+6.92%)
USD |
NASDAQ |
Sep 14, 12:24
Iovance Biotherapeutics Price : 9.195 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 8.25 | 8.695 | 8.075 | 8.60 | 12.39M |
| Sep 10, 2026 | 8.32 | 8.420 | 8.04 | 8.14 | 10.57M |
| Sep 09, 2026 | 8.655 | 8.73 | 8.32 | 8.43 | 11.94M |
| Sep 08, 2026 | 8.69 | 8.91 | 8.48 | 8.70 | 9.543M |
| Sep 04, 2026 | 8.74 | 8.90 | 8.635 | 8.79 | 8.080M |
| Sep 03, 2026 | 8.65 | 8.790 | 8.55 | 8.70 | 14.64M |
| Sep 02, 2026 | 8.31 | 8.69 | 8.295 | 8.62 | 12.39M |
| Sep 01, 2026 | 8.02 | 8.29 | 7.97 | 8.28 | 6.761M |
| Aug 31, 2026 | 7.945 | 8.17 | 7.66 | 8.17 | 12.13M |
| Aug 28, 2026 | 8.20 | 8.35 | 7.97 | 8.01 | 7.694M |
| Aug 27, 2026 | 8.08 | 8.319 | 7.95 | 8.26 | 7.437M |
| Aug 26, 2026 | 8.34 | 8.55 | 8.02 | 8.08 | 10.10M |
| Aug 25, 2026 | 8.16 | 8.48 | 8.031 | 8.44 | 11.91M |
| Aug 24, 2026 | 8.08 | 8.36 | 7.79 | 8.06 | 15.73M |
| Aug 21, 2026 | 9.08 | 9.30 | 8.145 | 8.29 | 27.81M |
| Aug 20, 2026 | 8.07 | 9.36 | 7.96 | 8.99 | 43.81M |
| Aug 19, 2026 | 7.20 | 8.055 | 7.19 | 7.99 | 24.25M |
| Aug 18, 2026 | 7.00 | 7.31 | 6.931 | 7.03 | 10.50M |
| Aug 17, 2026 | 6.84 | 7.250 | 6.703 | 7.10 | 14.81M |
| Aug 14, 2026 | 6.52 | 7.00 | 6.36 | 6.98 | 17.51M |
| Aug 13, 2026 | 6.74 | 6.81 | 6.424 | 6.52 | 15.68M |
| Aug 12, 2026 | 6.49 | 6.74 | 6.39 | 6.74 | 13.46M |
| Aug 11, 2026 | 6.48 | 6.525 | 6.18 | 6.49 | 10.38M |
| Aug 10, 2026 | 6.31 | 6.61 | 6.16 | 6.40 | 17.31M |
| Aug 07, 2026 | 6.57 | 6.92 | 5.88 | 6.34 | 30.97M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 380.28 |
| AVITA Medical, Inc. | 10.32 |
| Halozyme Therapeutics, Inc. | 108.25 |
| Neurocrine Biosciences, Inc. | 158.19 |
| Editas Medicine, Inc. | 2.79 |
Price Related Metrics
| PS Ratio | 11.60 |
| Price to Book Value | 5.659 |
| Earnings Yield | -7.85% |
| Market Cap | 4.165B |